- Home
- SMTC vs VKTX Comparison
SMTC vs VKTX Comparison
Compare SMTC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTC
- VKTX
- Stock Information
- Founded
- SMTC 1960
- VKTX 2012
- Country
- SMTC United States
- VKTX United States
- Employees
- SMTC N/A
- VKTX N/A
- Industry
- SMTC Semiconductors
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SMTC Technology
- VKTX Health Care
- Exchange
- SMTC Nasdaq
- VKTX Nasdaq
- Market Cap
- SMTC 4.3B
- VKTX 3.5B
- IPO Year
- SMTC N/A
- VKTX 2015
- Fundamental
- Price
- SMTC $60.67
- VKTX $26.98
- Analyst Decision
- SMTC Strong Buy
- VKTX Strong Buy
- Analyst Count
- SMTC 13
- VKTX 13
- Target Price
- SMTC $59.92
- VKTX $86.92
- AVG Volume (30 Days)
- SMTC 2.1M
- VKTX 9.7M
- Earning Date
- SMTC 08-25-2025
- VKTX 10-22-2025
- Dividend Yield
- SMTC N/A
- VKTX N/A
- EPS Growth
- SMTC N/A
- VKTX N/A
- EPS
- SMTC 0.29
- VKTX N/A
- Revenue
- SMTC $996,476,000.00
- VKTX N/A
- Revenue This Year
- SMTC $15.81
- VKTX N/A
- Revenue Next Year
- SMTC $9.69
- VKTX N/A
- P/E Ratio
- SMTC $209.25
- VKTX N/A
- Revenue Growth
- SMTC 22.22
- VKTX N/A
- 52 Week Low
- SMTC $24.05
- VKTX $18.92
- 52 Week High
- SMTC $79.52
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- SMTC 67.49
- VKTX 41.03
- Support Level
- SMTC $55.18
- VKTX $26.13
- Resistance Level
- SMTC $61.40
- VKTX $28.26
- Average True Range (ATR)
- SMTC 2.56
- VKTX 1.63
- MACD
- SMTC 0.68
- VKTX -0.39
- Stochastic Oscillator
- SMTC 94.33
- VKTX 19.82
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.